These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study. Ainiala H; Dastidar P; Loukkola J; Lehtimäki T; Korpela M; Peltola J; Hietaharju A Scand J Rheumatol; 2005; 34(5):376-82. PubMed ID: 16234185 [TBL] [Abstract][Full Text] [Related]
26. Clinical features of transverse myelitis associated with systemic lupus erythematosus. Zhang S; Wang Z; Zhao J; Wu DI; Li J; Wang Q; Su J; Xu D; Wang Y; Li M; Zeng X Lupus; 2020 Apr; 29(4):389-397. PubMed ID: 32054395 [TBL] [Abstract][Full Text] [Related]
27. Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus. Fragoso-Loyo H; Atisha-Fregoso Y; Nuñez-Alvarez CA; Llorente L Lupus; 2016 Apr; 25(4):364-9. PubMed ID: 26466614 [TBL] [Abstract][Full Text] [Related]
28. Myelopathy in systemic lupus erythematosus: clinical, laboratory, radiological and progression findings in a cohort of 1,193 patients. Costallat BL; Ferreira DM; Costallat LT; Appenzeller S Rev Bras Reumatol Engl Ed; 2016; 56(3):240-51. PubMed ID: 27267643 [TBL] [Abstract][Full Text] [Related]
29. Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus. Zonana-Nacach A; Yañez P; Jiménez-Balderas FJ; Camargo-Coronel A Lupus; 2007; 16(12):997-1000. PubMed ID: 18042596 [TBL] [Abstract][Full Text] [Related]
30. Neuropsychiatric manifestations in a consecutive cohort of systemic lupus erythematosus; a single center study. Abdul-Sattar AB; Goda T; Negm MG Int J Rheum Dis; 2013 Dec; 16(6):715-23. PubMed ID: 24382281 [TBL] [Abstract][Full Text] [Related]
31. Central nervous system involvement in systemic lupus erythematosus: Data from the Spanish Society of Rheumatology Lupus Register (RELESSER). Magro-Checa C; Ramiro S; Rúa-Figueroa I; Jimenez N; Del Campo-Pérez V; Martinez-Barrio J; Galindo-Izquierdo M; Calvo-Alén J; Uriarte-Isacelaya E; Tomero-Muriel E; Freire-González M; Martínez-Taboada V; Salgado E; Vela P; Mena-Vázquez N; Olivé A; Narváez J; Menor-Almagro R; Santos-Soler G; Hernández-Beriaín JA; Manero-Ruiz J; Aurrecoechea-Aguinaga E; Ibarguengoitia O; Montilla-Morales C; Bonilla-Hernán G; Torrente-Segarra V; Salman-Monte T; Ros-Vilamajo I; García-Villanueva MJ; Moriano-Morales C; Fito-Manteca C; Lozano-Rivas N; Bohórquez C; Pego-Reigosa JM Semin Arthritis Rheum; 2023 Feb; 58():152121. PubMed ID: 36375359 [TBL] [Abstract][Full Text] [Related]
32. Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus. Trevisani VF; Castro AA; Neves Neto JF; Atallah AN Cochrane Database Syst Rev; 2006 Apr; (2):CD002265. PubMed ID: 16625558 [TBL] [Abstract][Full Text] [Related]
34. Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus. Baca V; Lavalle C; García R; Catalán T; Sauceda JM; Sánchez G; Martínez I; Ramírez ML; Márquez LM; Rojas JC J Rheumatol; 1999 Feb; 26(2):432-9. PubMed ID: 9972981 [TBL] [Abstract][Full Text] [Related]
35. Myelitis in systemic lupus erythematosus. Li XY; Xiao HB; Pai P J Clin Neurosci; 2017 Oct; 44():18-22. PubMed ID: 28694045 [TBL] [Abstract][Full Text] [Related]
36. International survey on the management of patients with SLE. II. The results of a questionnaire regarding neuropsychiatric manifestations. Tincani A; Brey R; Balestrieri G; Vitali C; Doria A; Galeazzi M; Meroni PL; Migliorini P; Neri R; Tavoni A; Bombardieri S Clin Exp Rheumatol; 1996; 14 Suppl 16():S23-9. PubMed ID: 9049450 [TBL] [Abstract][Full Text] [Related]
37. Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus. Barile-Fabris L; Ariza-Andraca R; Olguín-Ortega L; Jara LJ; Fraga-Mouret A; Miranda-Limón JM; Fuentes de la Mata J; Clark P; Vargas F; Alocer-Varela J Ann Rheum Dis; 2005 Apr; 64(4):620-5. PubMed ID: 15769918 [TBL] [Abstract][Full Text] [Related]
38. Transverse myelitis as a first manifestation of systemic lupus erythematosus: a case report. Lopez Dupla M; Khamashta MA; Sanchez AD; Ingles FP; Uriol PL; Aguado AG Lupus; 1995 Jun; 4(3):239-42. PubMed ID: 7655499 [TBL] [Abstract][Full Text] [Related]
39. Successful treatment of transverse myelitis in a child with systemic lupus erythematosus. Baca V; Sanchez-Vaca G; Martínez-Muñiz I; Ramírez-Lacayo M; Lavalle C Neuropediatrics; 1996 Feb; 27(1):42-4. PubMed ID: 8677025 [TBL] [Abstract][Full Text] [Related]
40. Assessment of clinical manifestations, disease activity and organ damage in 996 Korean patients with systemic lupus erythematosus: comparison with other Asian populations. Joo YB; Bae SC Int J Rheum Dis; 2015 Feb; 18(2):117-28. PubMed ID: 25524656 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]